← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 1999Last known activity
Nov 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06630585OfficialPhase 3Nov 30, 2024
- NCT06630585CollaboratorPhase 3Nov 30, 2024
- NCT00271349Overall official - principal investigatorPhase 2Dec 1, 2005
- NCT01637818Overall official - principal investigatorN/ASep 1, 1999
- NCT01637818CollaboratorN/ASep 1, 1999
Details
- Last known activity
- Nov 30, 2024